Target Price | $14.00 |
Price | $2.90 |
Potential |
382.76%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Poseida Therapeutics Inc 2025 .
The average Poseida Therapeutics Inc target price is $14.00.
This is
382.76%
register free of charge
$20.00
589.66%
register free of charge
$10.00
244.83%
register free of charge
|
|
A rating was issued by 4 analysts: 4 Analysts recommend Poseida Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Poseida Therapeutics Inc stock has an average upside potential 2025 of
382.76%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 64.70 | 86.61 |
50.42% | 33.87% | |
Net Margin | -205.56% | -144.59% |
210.46% | 29.66% |
3 Analysts have issued a sales forecast Poseida Therapeutics Inc 2024 . The average Poseida Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued a net profit forecast Poseida Therapeutics Inc 2024 . The average Poseida Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.37 | -1.29 |
53.93% | 5.84% | |
P/E | negative | |
EV/Sales | 1.47 |
1 Analysts have issued a Poseida Therapeutics Inc forecast for earnings per share. The average Poseida Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Poseida Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Poseida Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.